AR030284A1 - Proceso para la sintesis de (2r, 2-alfa-r,3a) -2-[1-(3,5-bis(trifluorometil) fenil) etoxi]-3-(4-fluorofenil)-1,4-oxazina; dicho compuesto y sus formas polimorficas - Google Patents
Proceso para la sintesis de (2r, 2-alfa-r,3a) -2-[1-(3,5-bis(trifluorometil) fenil) etoxi]-3-(4-fluorofenil)-1,4-oxazina; dicho compuesto y sus formas polimorficasInfo
- Publication number
- AR030284A1 AR030284A1 ARP010102562A ARP010102562A AR030284A1 AR 030284 A1 AR030284 A1 AR 030284A1 AR P010102562 A ARP010102562 A AR P010102562A AR P010102562 A ARP010102562 A AR P010102562A AR 030284 A1 AR030284 A1 AR 030284A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- oxazine
- bis
- phenyl
- synthesis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Se refiere el compuesto (2R,2-alfa-R, 3a)-2-[1-(3,5-bis(trifluorometil)fenil]eloxi-3-(4-fluorofenil)-1,4-oxazina formas polimorficas de este compuesto y procesos para su preparacion. Este compuesto es util como intermediario en la síntesis de compuestos que poseen actividad farmacologica como antagonista del receptor de sustancia P. El proceso comprende poner en contacto un compuesto de la formula: (1) con un compuesto de la formula (2) en el cual Y se selecciona entre MgCI, MgBr, MgI y Li, en un primer solvente seguido por hidrogenacion, en un segundo solvente para dar el compuestos de la formula (3)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21020300P | 2000-06-08 | 2000-06-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR030284A1 true AR030284A1 (es) | 2003-08-20 |
Family
ID=22781976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010102562A AR030284A1 (es) | 2000-06-08 | 2001-05-29 | Proceso para la sintesis de (2r, 2-alfa-r,3a) -2-[1-(3,5-bis(trifluorometil) fenil) etoxi]-3-(4-fluorofenil)-1,4-oxazina; dicho compuesto y sus formas polimorficas |
Country Status (19)
Country | Link |
---|---|
US (1) | US6600040B2 (es) |
EP (1) | EP1292584A1 (es) |
JP (1) | JP2003535852A (es) |
KR (1) | KR20030007887A (es) |
CN (1) | CN1182125C (es) |
AR (1) | AR030284A1 (es) |
AU (1) | AU2001268170A1 (es) |
BR (1) | BR0111472A (es) |
CA (1) | CA2410404A1 (es) |
CZ (1) | CZ20024013A3 (es) |
EA (1) | EA004743B1 (es) |
HR (1) | HRP20020973A2 (es) |
HU (1) | HUP0400491A2 (es) |
IL (1) | IL152793A0 (es) |
MX (1) | MXPA02012101A (es) |
NZ (1) | NZ523389A (es) |
PL (1) | PL359137A1 (es) |
SK (1) | SK17082002A3 (es) |
WO (1) | WO2001094324A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001266690A1 (en) * | 2000-06-08 | 2001-12-17 | Merck And Co., Inc. | Process for the synthesis of (2r, 2-alpha-r)-4-benzyl-2-(1-(3,5-bis(trifluoromethyl)phenyl) ethoxy)-1,4-oxazin-3-one |
FR2876101B1 (fr) | 2004-10-05 | 2007-03-02 | Sidem Pharma Sa Sa | Procede de preparation enantioselective de derives de sulfoxydes |
WO2012146692A1 (en) | 2011-04-29 | 2012-11-01 | Sandoz Ag | Novel intermediates for the preparation of highly pure aprepitant or fosaprepitant |
CN103012305B (zh) * | 2011-09-23 | 2016-08-17 | 江苏豪森药业集团有限公司 | 一种福沙匹坦中间体的制备方法 |
CN103030668B (zh) * | 2011-10-09 | 2016-06-15 | 江苏豪森药业集团有限公司 | 一种制备福沙匹坦二甲葡胺的方法 |
CZ304770B6 (cs) | 2012-03-13 | 2014-10-08 | Zentiva, K.S. | Způsob výroby 3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluormethyl)fenyl)ethoxy)-3-(4-fluorfenyl)morfolino)methyl)-1H-1,2,4-triazol-5(4H)-onu (Aprepitantu) v polymorfní formě II |
CN102675240B (zh) * | 2012-04-13 | 2015-01-14 | 浙江海正药业股份有限公司 | 4-取代基-2-羟基吗啉-3-酮及其制备方法 |
CN104327009B (zh) * | 2014-09-24 | 2016-07-20 | 山东省生物医药科学院 | 一种阿瑞匹坦关键中间体的精制方法 |
CN104447607B (zh) * | 2014-12-12 | 2017-02-22 | 瑞阳制药有限公司 | 阿瑞匹坦中间体的制备方法 |
CN104557760A (zh) * | 2015-01-28 | 2015-04-29 | 武汉励合生物医药科技有限公司 | 阿瑞吡坦中间体的制备方法 |
CN106397349A (zh) * | 2016-08-31 | 2017-02-15 | 安徽省润生医药股份有限公司 | 一种阿瑞吡坦中间体及其制备方法 |
CN109516964B (zh) * | 2017-09-19 | 2022-05-31 | 鲁南制药集团股份有限公司 | 一种阿瑞匹坦中间体的制备方法 |
CN109694360A (zh) * | 2018-12-28 | 2019-04-30 | 凯瑞斯德生化(苏州)有限公司 | 一种阿瑞匹坦中间体的制备方法 |
CN110746371B (zh) * | 2019-11-20 | 2022-07-15 | 山东鲁抗医药股份有限公司 | 制备阿瑞匹坦的中间体及其制备方法与应用 |
CN111665016B (zh) * | 2020-06-09 | 2022-03-08 | 重庆交通大学 | 一种河道泡漩结构识别跟踪方法及通航预警方法 |
CN111829749A (zh) * | 2020-07-27 | 2020-10-27 | 中国空气动力研究与发展中心高速空气动力研究所 | 一种用于风洞超声速流校大行程单点移测装置及布线方法 |
CN113582982B (zh) * | 2021-06-15 | 2023-06-16 | 山东罗欣药业集团股份有限公司 | 一种nk1受体拮抗剂的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5719147A (en) * | 1992-06-29 | 1998-02-17 | Merck & Co., Inc. | Morpholine and thiomorpholine tachykinin receptor antagonists |
IL111960A (en) * | 1993-12-17 | 1999-12-22 | Merck & Co Inc | Morpholines and thiomorpholines their preparation and pharmaceutical compositions containing them |
SG52217A1 (en) | 1993-12-29 | 1998-09-28 | Merck Sharp & Dohme | Substituted morpholine derivatives and their use as therapeutic agents |
ZA985765B (en) | 1997-07-02 | 1999-08-04 | Merck & Co Inc | Polymorphic form of a tachykinin receptor antagonist. |
GB9813025D0 (en) | 1998-06-16 | 1998-08-12 | Merck Sharp & Dohme | Chemical synthesis |
EP1112259A4 (en) * | 1998-09-11 | 2002-01-09 | Merck & Co Inc | METHOD FOR SYNTHESISING N-BENZYL-3- (4-FLUOROPHENYL) -1,4-OXAZIN-2-ON |
CA2348526A1 (en) | 1998-10-30 | 2000-05-11 | Merck & Co., Inc. | Process for the preparation of 2-(r)-(1- (r)-(3,5-bis (trifluoromethyl) phenyl)ethoxy) -4-((5-dimethylaminomethyl) -1,2,3-triazol -4-yl)methyl) -3-(s)-(4- fluorophenyl) morpholine |
AU1230000A (en) * | 1998-10-30 | 2000-05-22 | Merck & Co., Inc. | Linear process for the preparation of a morpholine compound |
BR9916615A (pt) * | 1998-12-29 | 2001-10-23 | Upjohn Co | Método para a preparação de éteres de arila |
-
2001
- 2001-05-29 AR ARP010102562A patent/AR030284A1/es not_active Application Discontinuation
- 2001-06-04 SK SK1708-2002A patent/SK17082002A3/sk not_active Application Discontinuation
- 2001-06-04 KR KR1020027016609A patent/KR20030007887A/ko not_active Application Discontinuation
- 2001-06-04 MX MXPA02012101A patent/MXPA02012101A/es unknown
- 2001-06-04 JP JP2002501874A patent/JP2003535852A/ja not_active Withdrawn
- 2001-06-04 PL PL01359137A patent/PL359137A1/xx unknown
- 2001-06-04 WO PCT/US2001/018042 patent/WO2001094324A1/en not_active Application Discontinuation
- 2001-06-04 EP EP01946075A patent/EP1292584A1/en not_active Withdrawn
- 2001-06-04 BR BR0111472-7A patent/BR0111472A/pt not_active IP Right Cessation
- 2001-06-04 CN CNB018108962A patent/CN1182125C/zh not_active Expired - Fee Related
- 2001-06-04 CA CA002410404A patent/CA2410404A1/en not_active Abandoned
- 2001-06-04 AU AU2001268170A patent/AU2001268170A1/en not_active Abandoned
- 2001-06-04 EA EA200300002A patent/EA004743B1/ru not_active IP Right Cessation
- 2001-06-04 CZ CZ20024013A patent/CZ20024013A3/cs unknown
- 2001-06-04 IL IL15279301A patent/IL152793A0/xx unknown
- 2001-06-04 NZ NZ523389A patent/NZ523389A/en unknown
- 2001-06-04 HU HU0400491A patent/HUP0400491A2/hu unknown
- 2001-06-08 US US09/878,042 patent/US6600040B2/en not_active Expired - Fee Related
-
2002
- 2002-12-06 HR HR20020973A patent/HRP20020973A2/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US6600040B2 (en) | 2003-07-29 |
EA004743B1 (ru) | 2004-08-26 |
HUP0400491A2 (hu) | 2004-06-28 |
SK17082002A3 (sk) | 2003-04-01 |
CN1436178A (zh) | 2003-08-13 |
EA200300002A1 (ru) | 2003-04-24 |
EP1292584A1 (en) | 2003-03-19 |
AU2001268170A1 (en) | 2001-12-17 |
KR20030007887A (ko) | 2003-01-23 |
CZ20024013A3 (cs) | 2003-03-12 |
US20020052494A1 (en) | 2002-05-02 |
HRP20020973A2 (en) | 2005-02-28 |
CA2410404A1 (en) | 2001-12-13 |
CN1182125C (zh) | 2004-12-29 |
IL152793A0 (en) | 2003-06-24 |
JP2003535852A (ja) | 2003-12-02 |
BR0111472A (pt) | 2004-01-06 |
MXPA02012101A (es) | 2003-04-25 |
PL359137A1 (en) | 2004-08-23 |
NZ523389A (en) | 2004-08-27 |
WO2001094324A1 (en) | 2001-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR030284A1 (es) | Proceso para la sintesis de (2r, 2-alfa-r,3a) -2-[1-(3,5-bis(trifluorometil) fenil) etoxi]-3-(4-fluorofenil)-1,4-oxazina; dicho compuesto y sus formas polimorficas | |
CO5640127A2 (es) | Compuestos quimicos y composiciones farmaqceuticas a base de indolizinas | |
SG158888A1 (en) | Exo- and diastereo- selective syntheses of himbacine analogs | |
PE20060562A1 (es) | Derivados de amino-piperidina como agonistas de los receptores de melanocortina mc3 y/o mc4 | |
DK1778677T3 (da) | Heterocykliske kondenserede forbindelser der er egnede som antidiuretiske midler | |
AR057987A1 (es) | Compuestos agonistas de cb1 (receptor cannabinoide) | |
EA200200646A1 (ru) | Соединения мочевины, обладающие активностью антагонистов мускариновых рецепторов | |
AR057227A1 (es) | Metodo para usar antagonistas de il6 con inhibidores del proteasoma | |
ATE515702T1 (de) | Verfahren, mixturen, kits und zusammensetzungen bezüglich der analytbestimmung | |
PE20060483A1 (es) | Compuestos heterociclicos como antagonistas de nk1 | |
ATE524433T1 (de) | Trpv1 agonisten , zubereitungen die diese enthalten und ihre anwendung | |
DK1337518T3 (da) | Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren | |
AR005010A1 (es) | Metodo para convertir metanol a olefinas | |
PE20071321A1 (es) | Bencensulfonil-cromano, tiocromano, tetrahidronaftaleno e inhibidores de gamma secretasa relacionados | |
PE20060988A1 (es) | Sintesis asimetrica de dihidrobenzofuranos sustituidos | |
MXPA05010824A (es) | Compuestos biciclicos como antagonistas del receptor nr2b. | |
PE86499A1 (es) | Forma polimorfa de 2-(r)-(1-(r)-3,5-bis(trifluorometil)-fenil)etoxi)-3-(s)-(4-fluoro)fenil-4-(3-(5-oxo-1h,4h-1,2,4-triazolo)metilmorfolina util como un antagonista de receptor de taquiquinina | |
PE20001084A1 (es) | Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas | |
Marcelli et al. | Domino synthesis of 1, 3, 5-trisubstituted hydantoins: a DFT study | |
AR028817A1 (es) | Compuestos derivados de la 1-arenosulfonil-2-arilo-pirrolidina, su empleo, un procedimiento para obtenerlos y medicamentos que los contienen | |
SG158884A1 (en) | An exo-selective synthesis of himbacine analogs | |
PE20040682A1 (es) | Derivados de ciclobutano como antagonistas de nk1 | |
ES2166977T3 (es) | Nuevo procedimiento para preparar compuestos intermedios de plaguicidas. | |
DE50213883D1 (de) | Verfahren zur hydrierung von flüssigen organischen verbindungen | |
CO4770917A1 (es) | Compuestos de dihalopropeno, su uso e intermedios para su produccion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |